RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-7.57%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.97B
AUM Growth
+$3.97B
(-8.2%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
30.63%
Holding
141
New
5
Increased
76
Reduced
8
Closed
5
Top Buys
| 1 |
DexCom
DXCM
|
$24.2M |
| 2 |
Idexx Laboratories
IDXX
|
$21.2M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$18.1M |
| 4 |
Amylyx Pharmaceuticals
AMLX
|
$12.8M |
| 5 |
Penumbra
PEN
|
$12.4M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$18.8M |
| 2 |
Intuitive Surgical
ISRG
|
$18.6M |
| 3 |
Immuneering
IMRX
|
$17.6M |
| 4 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$13M |
| 5 |
XENT
Intersect ENT, Inc
XENT
|
$10.9M |
Sector Composition
| 1 | Healthcare | 95.24% |
| 2 | Consumer Staples | 1.53% |
| 3 | Industrials | 0.67% |
| 4 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Shattuck Labs
STTK
$60.4M
| $1.34M | 0.03% |
313,499
| – | – |
|
|
PSTX
127
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.3M | 0.03% |
289,754
| – | – |
|
128
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
| $108K | ﹤0.01% |
134,028
| – | – |
|
129
Day One Biopharmaceuticals
DAWN
$769M
| – | – |
-381,939
| Closed | -$6.44M |
|
|
130
Immuneering
IMRX
$240M
| – | – |
-1,089,816
| Closed | -$17.6M |
|
131
Nurix Therapeutics
NRIX
$719M
| – | – |
-321,050
| Closed | -$9.29M |
|
|
WHWK
132
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$88.1M
| – | – |
-538,835
| Closed | -$13M |
|
133
Acumen Pharmaceuticals
ABOS
$83.6M
| – | – |
-1,571,918
| Closed | -$10.6M |
|